Trial Profile
A Double-Blind, Multicentre, Randomised, Parallel-group, Placebo-controlled Study Assessing the Efficacy and Safety of Escitalopram in Post-Myocardial Infarction Patients Suffering from Depressive Symptoms.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2012
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depression
- Focus Registrational; Therapeutic Use
- Sponsors Lundbeck A/S
- 03 Jun 2011 New trial record